Fig. 1

Dose–response association between MEDLIFE, the components of the metabolic syndrome and hs-CRP, HOMA-IR in ENRICA cohort. Analyses were adjusted as in Model 3. HOMA-IR Homeostatic Model Assessment for Insulin Resistance, Hs-CRP highly sensitive C-reactive protein